Related references
Note: Only part of the references are listed.Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficacy and Effectiveness Studies
Alireza Atri et al.
NEURODEGENERATIVE DISEASES (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Long-term progression of Alzheimer's disease in patients under antidementia drugs
Sophie Gillette-Guyonnet et al.
ALZHEIMERS & DEMENTIA (2011)
Combination Therapy for Alzheimerʼs Disease
Laxeshkumar Patel et al.
DRUGS & AGING (2011)
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
Jason T. Olin et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease
David Wilkinson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O. L. Lopez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Susan D Rountree et al.
Alzheimers Research & Therapy (2009)
Long-term course and effectiveness of combination therapy in Alzheimer disease
Alireza Atri et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
Anton P. Porsteinsson et al.
CURRENT ALZHEIMER RESEARCH (2008)
Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies
Gordon K. Wilcock et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Meta-analysis of six-month memantine trials in Alzheimer's disease
Rachelle Smith Doody et al.
ALZHEIMERS & DEMENTIA (2007)
Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease
David Wilkinson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials
Bengt Winblad et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil - An exploratory reanalysis
Frederick A. Schmitt et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Activities of daily living in moderate-to-severe Alzheimer disease: An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment
Howard H. Feldman et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
AP Periclou et al.
ANNALS OF PHARMACOTHERAPY (2004)
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease
K Rockwood
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
H Feldman et al.
NEUROLOGY (2001)
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
B Winblad et al.
NEUROLOGY (2001)
Share Paper
